410
Participants
Start Date
June 30, 2003
Primary Completion Date
April 30, 2004
Study Completion Date
December 31, 2006
Anti-Giardia and antihelmintic treatment (secnidazole or albendazole)
Every 4 weeks: Secnidazole (70mg/ml suspension, 0.5ml per kg of body weight) or a placebo was administered Every 12 weeks: Albendazole (syrup, 200mg)
Anti-Giardia treatment only (secnidazole or albendazole)
Every 4 weeks: Secnidazole (70mg/ml suspension, 0.5ml per kg of body weight) Every 12 weeks: placebo of Albendazole
Control group (placebo)
Every 4 weeks: Secnidazole placebo Every 12 weeks: Albendazole placebo
National Institute of Preventive and Social Medicine, Mohakhali
University of Cambridge
OTHER